In a significant move to address the healthcare needs of thalassemia patients in the Kurdistan Region, Prime Minister Masrour Barzani has approved the treatment of 100 thalassemia patients outside the Kurdistan Region. This decision comes as part of the government's ongoing efforts to ensure the well-being of those affected by the genetic blood disorder.

To implement this initiative, the Ministry of Health of the Kurdistan Regional Government, in collaboration with the Office of Foreign Relations, has been instructed to take necessary measures to facilitate the treatment of patients in both Turkey and Jordan. This strategic move aims to leverage specialized medical facilities and expertise available in neighboring countries.

Prime Minister Barzani, on July 23, sanctioned the allocation of approximately three billion Iraqi dinars ($2.3 million) dedicated to providing essential medical supplies and treatment for thalassemia patients in the Kurdistan Region. This financial commitment underscores the government's dedication to supporting individuals grappling with thalassemia and reflects a proactive approach in ensuring they receive the necessary care.

This recent decision follows an earlier announcement on April 19, where Prime Minister Barzani declared the availability of free testing and treatment for patients suffering from thalassemia. The government's comprehensive approach seeks to not only provide treatment but also promote early detection through accessible testing services.

The Kurdistan Region is home to approximately 4,000 thalassemia patients, and these recent measures underscore the government's commitment to addressing the healthcare needs of this specific demographic. By approving treatment abroad and allocating funds for medical supplies, Prime Minister Barzani's administration demonstrates a commitment to the well-being of thalassemia patients, ensuring they receive the best possible care to manage their condition.